Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation

Transplant Proc. 2001 May;33(3):2304-6. doi: 10.1016/s0041-1345(01)02000-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / therapeutic use*
  • Diabetes Mellitus, Type 1 / surgery*
  • Diabetic Nephropathies / surgery*
  • Disease-Free Survival
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Graft Survival
  • Humans
  • Injections, Intravenous
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / methods
  • Kidney Transplantation / mortality
  • Lymphocyte Count
  • Male
  • Pancreas Transplantation / immunology*
  • Pancreas Transplantation / methods
  • Pancreas Transplantation / mortality
  • Platelet Count
  • Retrospective Studies
  • Survival Rate
  • Time Factors

Substances

  • Antilymphocyte Serum